Skip to main content
NCBI home page
Cambridge Open Access logoLink to Cambridge Open Access
. 2011 Jun 10;138(12):1607–1619. doi: 10.1017/S0031182011000412

Screening trematodes for novel intervention targets: a proteomic and immunological comparison of Schistosoma haematobium, Schistosoma bovis and Echinostoma caproni

MELISSA HIGÓN 1,2, GRAEME COWAN 1, NORMAN NAUSCH 1, DAVID CAVANAGH 1, ANA OLEAGA 4, RAFAEL TOLEDO 2, J RUSSELL STOTHARD 6, ORETO ANTÚNEZ 5, ANTONIO MARCILLA 2, RICHARD BURCHMORE 3, FRANCISCA MUTAPI 1,*
PMCID: PMC3179331  PMID: 21729355

SUMMARY

With the current paucity of vaccine targets for parasitic diseases, particularly those in childhood, the aim of this study was to compare protein expression and immune cross-reactivity between the trematodes Schistosoma haematobium, S. bovis and Echinostoma caproni in the hope of identifying novel intervention targets. Native adult parasite proteins were separated by 2-dimensional gel electrophoresis and identified through electrospray ionisation tandem mass spectrometry to produce a reference gel. Proteins from differential gel electrophoresis analyses of the three parasite proteomes were compared and screened against sera from hamsters infected with S. haematobium and E. caproni following 2-dimensional Western blotting. Differential protein expression between the three species was observed with circa 5% of proteins from S. haematobium showing expression up-regulation compared to the other two species. There was 91% similarity between the proteomes of the two Schistosoma species and 81% and 78·6% similarity between S. haematobium and S. bovis versus E. caproni, respectively. Although there were some common cross-species antigens, species-species targets were revealed which, despite evolutionary homology, could be due to phenotypic plasticity arising from different host-parasite relationships. Nevertheless, this approach helps to identify novel intervention targets which could be used as broad-spectrum candidates for future use in human and veterinary vaccines.

Key words: Schistosoma, S. bovis, S. haematobium, Echinostosma caproni, trematode, proteomics, immunology, DIGE, DIA, vaccine development

INTRODUCTION

Schistosomes are important blood-fluke parasites of humans and domestic livestock (Rollinson et al. 1997). These trematodes are divided into 4 main groups: Schistosoma mansoni group, S. haematobium group, S. indicum group and S. japonicum group (Secor and Colley, 2005). Echinostomes are also trematodes but, unlike schistosomes, they develop and are restricted to the intestinal lumen of the definitive host and do not have a tissue invasive phase (Toledo and Fried, 2005; Toledo et al. 2009).

Human schistosomiasis is a neglected tropical disease and a major public health concern in Africa, the Middle East, Asia and South America. Some 200 million people are infected with schistosomes, with a further 700 million at risk of infection in tropical and subtropical regions (Engels et al. 2002). As there is currently no available vaccine for this disease in people (Bergquist et al. 2008), the foundation of control is based upon provision of chemotherapy to afflicted communities, in particular mass drug administration of the anthelmintic praziquantel (Doenhoff et al. 2009). However, the search for an effective vaccine continues to be a key priority (Secor and Colley, 2005).

Urinary schistosomiasis, caused by Schistosoma haematobium, is the most prevalent form of schistosomiasis in Africa and the Middle East. Children carry the heaviest burden of infection with as many as 100% of primary school children infected in areas such as our study sites in Zimbabwe (Midzi et al. 2008). Children younger than school-age can also be infected and begin to exhibit disease (Garba et al. 2010). As a result, schistosome-related morbidities include both non-immunological forms (blood in the urine, pain during urination, anaemia, growth retardation, poor cognition and memory) and immune-mediated forms (tissue damage and organomegaly) (Midzi et al. 2008). Immuno-pathological reactions against schistosome eggs trapped in the tissues leads to inflammatory and obstructive disease in the bladder, ureter and kidney as well as fibrosis. Urinary schistosomiasis likely predisposes to bladder cancer and HIV infection (Stoever et al. 2009).

To develop vaccines protective against infection and/or pathology based on natural immune responses against schistosomes, there is ongoing research both in humans and animals in a context of experimental and natural schistosomiasis (Hagan et al. 1991; Dunne et al. 1992; Demeure et al. 1993; Grogan et al. 1997; Mutapi et al. 1998). Several studies have demonstrated similarities between different Schistosoma species in terms of life-histories and immunological aspects (Verjovski-Almeida et al. 2003; Capron et al. 2005; Berriman et al. 2009; Zhou et al. 2009), but little is known about molecular phenotypic differences that may be involved in host adaptation which might affect the efficacy of future vaccines. Despite the demonstration that antibody-mediated responses can protect against schistosome infection in experimental models, current human schistosome vaccine research, based on antibody-mediated protection, has stalled with the failure of many of the vaccine candidate antigens to enter Phase III clinical trials (Hagan and Sharaf, 2003). Limitations in our current understanding of the development of protective anti-schistosome responses against specific antigenic proteins as well as the parasite's biology (particularly antigen expression patterns) may be contributing to the slow development of effective anti-schistosome vaccines.

To shed light on these issues, comparison of the protein expression of S. haematobium adult worms with other trematode parasites could be illuminating especially in reference to S. bovis which is a ‘molecular’ analogue of S. haematobium and an experimental model for vaccine research (Capron et al. 2005). Comparison with other more distantly-related trematodes, e.g. Echinostoma caproni, is also useful by providing inferences into putative responses to different life history tracts, i.e. echinostomes do not have a tissue phase in the definitive host, and present an opportunity to investigate host-related adaptations in protein expression patterns. Although S. bovis and S. haematobium differ in their definitive hosts and in their niches within the host vasculature (Vercruysse and Gabriel, 2005), being sufficiently closely related in terms of evolutionary distance (Bowles et al. 1995; Webster et al. 2006), they have an ability to hybridise (Huyse et al. 2009). As S. bovis is much easier to keep in laboratory passage in rodents (Agnew et al. 1989) as well as eliciting similar cross-immunogenic profiles (Losada et al. 2005), makes study of S. bovis particularly informative. However, significant differences are known: for example, early studies of the S. haematobium vaccine candidate glutathione-S-transferase (28 kDa GST) showed inter-species variation in the coding regions of S. haematobium vs. S. bovis vs. S. japonicum 28 kDa GST. This variation gives rise to phenotypic differences associated with host immunity (Trottein et al. 1992).

To date, several studies using proteomic approaches have compared protein expression patterns between different helminth life stages (Curwen et al. 2004; Jolly et al. 2007; Wang et al. 2010), including parasites of different sexes and parasite development in different hosts (Toledo et al. 2004; Cheng et al. 2005). There have been no comparative proteomic studies on different trematode species which could lead to novel intervention targets with broader spectra and a better understanding of parasite-related host immune modulation (Harnett and Harnett, 2010). Previous evolutionary and ecological studies have been carried out using genetic techniques such as micro-array (transcriptome) or genome sequencing (Cieslak and Ribera, 2009) and these have given important insights into the biology of the parasites. These techniques do not take into account post-transcriptional regulation of protein expression (López, 2007; Schrimpf and Hengartner, 2010) and cannot determine the degree of epitope cross-reactivity between parasite species. Moreover, the proteomic approach is particularly useful in non-model organisms (López, 2007; Ramm et al. 2009). Comparative proteomic approaches have been successfully used in other more general molecular studies: for example, assessing the divergence between different rodent species (Aquadro and Avise, 1981).

In this study, we have used a proteomic approach to compare phenotypic differences between the three different parasite species in terms of protein expression and immunogenicity. We compared protein expression patterns and immune cross-reactivity between S. haematobium, S. bovis and E. caproni which may indicate proteins involved in the adaptation to different hosts and different niches potentially warranting further scrutiny as potential vaccines targets for schistosomiasis as well as several other trematode diseases.

MATERIALS AND METHODS

Parasites and experimental infections

The techniques used for the maintenance of Echinosotoma caproni in the laboratory have been described in detail elsewhere (Toledo et al. 2004). Briefly, encysted metacercariae of E. caproni were removed from the kidneys and pericardial cavities of experimentally infected Biomphalaria glabrata snails and used to infect golden hamsters (Mesocricetus auratus). Outbred male golden hamsters, weighing 45–60 g, were infected through a stomach tube with 75 metacercariae each of E. caproni. The worm egg release by each animal was monitored daily as described previously (Toledo et al. 2003). Soluble adult worm antigens (SWAP) were prepared from adult worms collected from the intestine of hamsters 6 weeks post-infection with 100 metacercariae of E. caproni following previously published protocols (Toledo et al. 2003). For S. haematobium infections used for the serological studies, parasite eggs obtained from urine of S. haematobium-infected children in Zanzibar (Stothard et al. 2002) were hatched and used to infect Bulinus wrighti snails with 5 miracidia per snail. Upon infection patency 150 cercariae were pooled from these shedding snails and used to infect golden hamsters by the paddling technique; all experiments were in accordance with ethical principles in animal research and Home Office (UK) approvals.

Adult S. haematobium SWAP was obtained freeze dried from the Theodor Bilharz Institute (Giza, Egypt). To prepare this fraction, worms were perfused in saline buffer from hamsters, washed in PBS (pH 7·4), homogenized, centrifuged to obtain the soluble fraction and freeze-dried in aliquots (5 mg/mL). These were reconstituted with distilled water as required. Freeze-dried adult S. bovis SWAP from sheep was prepared as previously described in detail elsewhere (Oleaga and Ramajo, 2004). SWAP preparations were prepared following similar protocols to reduce proteome variations due to different preparation approaches.

Rodent sera

For the immunological cross-reactivity assays, the antigen recognition patterns of sera from hamsters infected with S. haematobium and E. caproni were determined. For E. caproni, a pool was made from sera collected at 5, 6 and 10 weeks post-infection (hamsters normally make parasite-specific antibodies from 5 weeks) from 5 hamsters. After clotting overnight at 4°C, serum was separated from the clot by centrifugation. All the sera and the antigens were stored at −20°C until use. For sera from schistosome infected hamsters, Syrian golden hamsters were infected with 150 cercariae by paddling and bled 12 weeks post-infection. After clotting, blood collected from each hamster was centrifuged at 1400 g for 5 min to collect sera which were snap frozen in liquid nitrogen for long-term storage in liquid nitrogen. A pool of sera was made from 5 hamsters for use in this study. There were no experiments of hamsters infected with S. bovis parasites.

Preparations for CyDye labelling for DIGE

CyDye DIGE Fluor minimal dyes (GE Healthcare) were reconstituted following the manufacturer's instructions. 50μg protein of each sample were labelled with either Cy3 or Cy5. The sample volumes were adjusted to 18μL with labelling buffer (7M urea, 2M thiourea, 4% CHAPS, (w/v), 25 mM Tris Base; pH 8·5), followed by addition of 1μL dye (400 pmol) to each individual sample. The samples were left on ice for 30 minutes in the dark, followed by adding 1μL of 10 mmol/L lysine to stop the reaction.

Two-dimensional differential in gel electrophoresis (2D-DIGE)

To compare the parasite proteomes in 2D-DIGE assays, three gels were ran – one for each pair of samples. Differentially labelled samples were mixed into the same tube with 210μl of rehydration buffer (7M urea, 2M thiourea, 4% CHAPS, 5% DTE (dithioerythritol), 0·8% IPG buffer 3–10 pH and bromophenol blue). Thereafter, the first dimension i.e. isoelectric focusing (IEF) and second dimension were run following previously described protocols (Mutapi et al. 2005) using the IEF protocol for 13 cm IPG strips; rehydration for 14 h at 20 V, 500 V for 1 h, 1000 V for 1 h and 8000 V for 3 h and performing the second dimension using 12% polyacrylamide gels with SDS buffer. Images from these gels were subsequently analysed as described below.

Image analysis and mass spectrometry

Gels were scanned on a Typhoon spectrophotometer (GE Healthcare) at the appropriate excitation/emission wavelength for each fluorophore Cy3 (532/580 nm) and Cy5 (633/670 nm) at 50 microns resolution. The images were analyzed using the Difference In–gel Analysis (DIA) module of Decyder software version 7.0 (GE Healthcare). The protein spots showing greater than 5-fold differences in relative abundance between parasite preparations were considered as differentially expressed proteins. The 5-fold difference was used to reduce the likelihood of detecting spurious differences. Proteins from the different trematodes were identified by comparing DIGE images with the proteomic map of S. haematobium (Mutapi et al. 2005) and E. caproni (Sotillo et al. 2010) since there is no complete genome or protein sequence available for any of the three species studied. S. haematobium protein identities on the proteome map were obtained from a Coomassie Blue-stained reference gel which had been prepared and processed to obtain MS/MDS data which were submitted for an MS/MS ion search via the Mascot search engine (Matrix Science), and non-redundant National Center for Biotechnology Information (NCBI) database (Mutapi et al. 2005). Briefly, plugs of 1·4 mm were excised from the reference Coomassie Blue-stained gel and subjected to in-gel trypsin digestion in an Ettan Spot Handing Workstation (GE Healthcare), in accordance with standard protocols (Amersham).

The resulting tryptic peptides were solubilized in 0·5% formic acid and were fractionated by nanoflow high-performance liquid chromatography on a C18 reverse phase column (GE Healthcare), and elution was performed with a continuous linear gradient of 40% acetonitrile for 20 min. The elutants were analyzed by online electrospray tandem MS (MS/MS) by use of a Qstar Pulsar mass spectrometer (Applied Biosystems). A 3 sec survey scan preceded each MS/MS data-collection cycle of 4 product ion scans of 3 sec each, and this gave a duty cycle of 15 sec. Data were submitted for an MS/MS ion search via the Mascot search engine (Matrix Science), and both locally established databases for S. mansoni EST sequences and the present non-redundant National Center for Biotechnology Information (NCBI) database were searched.

Two-dimensional electrophoresis and Western blotting

In order to determine cross-reactive antigens, 2D gel electrophoresis (2DE) was conducted on 7 cm gels as above, with some modifications. 100 μg of protein were solubilised in rehydration buffer (7 M urea, 2 M thiourea, 4% CHAPS (w/v), 65 mM DTE and trace bromophenol blue) and 0·8% IPG buffer (pH 3–10) to make a total volume of 125μL. Each protein preparation was then added to a 7 cm linear pH 3–10 IPG strip and the IEF was performed following the following protocol (1) passive rehydration for 14 h ; (2) 500 V for 30 min; (3) 1000 V for 30 min; (4) 8000 V for 4 h followed by equilibration in 2 mL of 1% DTE for 15 min and 2 mL of 4% iodoacetamide in equilibration buffer containing 6 M urea, 0·375 M Tris pH 8·8, 2% SDS and 20% glycerol. The second dimension was performed using 10% polyacrylamide precast gels from Invitrogen. Proteins from SDS–PAGE were stained with Coomassie blue or transferred onto nitrocellulose membranes in 25 ml 20X transfer buffer (Invitrogen), methanol 10% (v/v). After confirming transfer by staining with 0·1% Ponceau S (Sigma), membranes were blocked with TBS Start Block buffer T20 (Invitrogen) for 1 h at room temperature. After washing with TBS containing 0·05% Tween-20 (TBST), blots were incubated overnight at 4°C with a pool of 10 serum samples of E. caproni-infected hamsters, or S. haematobium-infected hamsters or negative control sera at 1:200 dilution in TBS Start Block buffer. The membrane was then washed three times for 10 min each time in TBS, 0·05% Tween 20, 0·5% Triton-X100 (TBS/TT). Bound antibodies were detected by incubating blots for 1 h at RT with horseradish peroxidase (HRP)-conjugated rabbit anti-Syrian hamster IgG (Abcam), in blocking buffer. After washing four times for 10 min each time in TBS/TT and once in TBS alone, recognised antigens were visualized using ECL Plus (Amersham) following the manufacturer's instructions, and exposed to X-OMAT film (Kodak) for 10 sec. Images from Western blotting and Coomassie blue staining were digitalised and matched by using ImageMaster software (GE Healthcare).

RESULTS

Proteome comparisons

The 2D-DIGE gels were run comparing the 3 proteomes as shown in Fig.1. DIA analysis of the gels showed both quantitative and qualitative differences. There was more similarity between the two schistosome species than between Echinostoma and Schistosoma. On the first gel comparing S. haematobium and S. bovis, 1701 spots representing different proteins (including different isoforms) were detected, with 91% showing similar expression levels (Fig. 2A). 5·4% of the proteins showed increased expression in S. haematobium by our criteria of 5-fold or greater difference in abundance on the gel while 3·6% showed increased expression in S. bovis. On the second gel, comparing S. haematobium vs. E. caproni, 1967 spots were detected with 81% showing similar expression levels. 8·4% of the protein spots showed increased expression in S. haematobium and 10·6% showed increased expression in E. caproni while 81% were present in similar amounts on both gels (Fig. 2B).

Fig. 1.

Fig. 1

Open in a new tab
2D-DIGE images comparing pairs of different helminth species’ adult worm proteomes.
  1. S. haematobium (green spots) vs. S. bovis (red spots).
  2. S. haematobium (red spots) vs. E. caproni (green spots).
  3. S. bovis (red spots) vs. E. caproni (green spots).
    Identified proteins are indicated by solid arrows (for S. haematobium), dashed arrows (for E. caproni) and encircled (for both).

Fig. 2.

Fig. 2

Open in a new tab
Pair-wise comparison of protein expression patterns in adult worm proteomes of pairs of parasite species from DIA plug-in analysis. This analysis co-detects the spots from the image and, after normalization, compares the volume of a spot from the two samples as a volume ratio. Spots were detected as different if the volume ratio threshold difference was ⩾ 5 fold. Each gel image shows different expression patterns on individual species gels.
  1. Gels showing the DIA analyses of S. haematobium vs. S. bovis on the gels from each of the two species. Green marks represent proteins over-expressed in S. haematobium. Red marks represent proteins over-expressed in S. bovis. Blue represents spots expressed to similar levels in the two species.
  2. Gels showing the DIA analyses of S. haematobium vs. E. caproni on the gels from each of the two species. Green marks represent proteins over-expressed in S. haematobium. Red marks represent proteins over-expressed in E. caproni. Blue represents spots expressed to similar levels in the two species.
  3. Gels showing the DIA analyses of S. bovis vs. E. caproni on the gels from each of the two species. Green marks represent proteins over-expressed in E. caproni. Red marks represent proteins over-expressed in S. bovis. Blue represents spots expressed to similar levels in the two species.
    The histograms represents spot frequencies plotted against logarithm volume ratio.

On the final gel, comparing S. bovis vs. E. caproni, 1757 spots were detected with 78·6% showing similar expression levels. 9·1% of the protein spots showed increased expression in S. bovis and 12·3% showed increased expression in E. caproni (Fig. 2C). It was possible to identify some of the proteins present on the adult worm proteomes by comparing DIGE images with the proteomic maps of S. haematobium and E. caproni. Details of S. haematobium protein identities from mass spectrometry of proteins have already been published (Mutapi et al. 2005) while those from E. caproni have not previously been published and are given in Table 1 and annotated in Fig. 3.

Table 1.

Proteins identified in the adult soluble worm preparation of Echinostoma caproni using MASCOT search engine (Matrix Science)

graphic file with name S0031182011000412_tab1.jpg

Open in a new tab

Fig. 3.

Fig. 3

Open in a new tab

Coomassie blue-stained 2-dimensional E. caproni gel showing spots excised, and identified by MASCOT. Corresponding protein identities are given in Table 1.

The expression patterns of pairs of proteins spots between different parasite species are compared in Table 2. The heat shock protein HSP70 was more highly expressed in S. haematobium compared to S. bovis or E. caproni. Between the Schistosoma species, there were similar expression levels of metabolic enzymes, signal transduction molecules and detoxification enzymes, but expression levels of these proteins differed between the latter species and E. caproni. Three homologous proteins were identified in S. haematobium and E. caproni; protein disulfide isomerase, enolase and GST, but the gel migration showed that they differed in molecular weights between the two species.

Table 2.

Proteins differentially expressed between the different trematodes identified on the 2-dimensional gel in Differential in Gel Electrophoresis (DIGE)

graphic file with name S0031182011000412_tab2.jpg

Open in a new tab

Immune cross-reactivity

Using sera from hamsters infected with S. haematobium and E. caproni, we performed 2D Western-blot analyses. As expected, homologous pairs of sera and antigen showed the highest levels of recognition (Fig. 4). Interestingly, heterologous sera also detected spots in the gels, confirming cross-reactivity among these trematode species. In this context, S. haematobium sera recognised more antigenic spots in the S. bovis proteome than in E. caproni. There was some cross-reactivity, between E. caproni and S. haematobium. Three spots in the E. caproni proteome which were identified as isoforms of GADPH reacted with sera from both E. caproni-infected and S. haematobium-infected hamsters. However, sera from E. caproni-infected hamsters did not react against GADPH in the S. haematobium proteome.

Fig. 4.

Fig. 4

Open in a new tab
Antigen recognition profile of sera from trematode-infected hamsters.
  1. S. bovis SWAP antigen recognition by sera from E. caproni-infected hamsters.
  2. S. bovis SWAP antigen recognition by sera from S. haematobium-infected hamsters.
  3. S. haematobium SWAP antigen recognition by sera E. caproni from infected hamsters.
  4. S. haematobium SWAP antigen recognition by sera from S. haematobium-infected hamsters.
  5. E. caproni SWAP antigen recognition by sera from E. caproni-infected hamsters.
  6. E. caproni SWAP antigen recognition by sera from S. haematobium-infected hamsters.
    A novel E. caproni antigen GAPDH is encircled.

DISCUSSION

Trematodes are an evolutionarily distinct group of parasites of importance to both human and veterinary medicine in the diseases that they cause. Understanding similarities and differences in their phenotypic molecular biology is important in several areas such as drug target discovery, vaccine design and development of helminth-derived therapeutic agents for immune disorders; also in the context of when infections are acquired during childhood and beyond. Here, a comparative analysis of the proteome of three species of trematode: S. haematobium, S. bovis and E. caproni using 2D-DIGE was conducted. S. haematobium and S. bovis are closely related species and can undergo hybridisation (Huyse et al. 2009), the results obtained here show that there are also significant proteomic differences, even among conserved proteins. These species-specific differences could be due to phenotypic plasticity arising from different host-parasite relationships (Schrimpf and Hengartner, 2010). Evolutionary and phylogenetic studies have demonstrated that highly expressed genes tend to evolve more slowly (Hirsh and Fraser, 2001; Schrimpf and Hengartner, 2010), nonetheless here we demonstrate that some of these conserved proteins differ in molecular weight, most likely due to post-translational modifications which should be explored further particularly as vaccine candidates.

It was possible to identify some of the proteins present in the proteomes by searching public databases, but due to the limited sequence information available on these three trematodes, a large number of the proteins remain unidentified (Nowak and Loker, 2005). Comparing the proteomes of the two schistosome species, only HSP70 identified from the Coomassie Blue-stained reference gel showed increased expression in S. haematobium despite the 10% difference in protein expression levels detected by the DIA analysis. The DIGE analysis can detect much lower concentrations of proteins than Coomassie staining. Thus, a large number of proteins present on the DIGE gel were present at a concentration too low to be detected from the Coomassie Blue-stained gel for mass spectrometry. These proteins accounted for some of the 10% differences between the two schistosomes. Our results showing differential expression of HSP70 are consistent with those from a different trematode genus, Fasciola where F. hepatica and F. gigantica show different levels of HSP70 expression (Smith et al. 2008). Furthermore we have previously reported differences in HSP70 expression in E. caproni parasites from low vs. high compatible hosts (Higón et al. 2008). Therefore, expression levels of HSP70 seem to depend on the host environment and this could be a common mechanism used by different parasites in order to adapt to different hosts. The sequencing of the genome and subsequent identification of all proteins present in the proteome of all 3 species compared in this study will greatly strengthen such comparative approaches as they will allow more robust comparison of identified proteins as well as comparisons of the number of isoforms and the relative abundance of each isoform to the compared.

There were more differentially expressed proteins between the two different genera. Most proteins identified in both E. caproni and S. haematobium (with known identities) are homologues (protein disulfide isomerase, enolase and GST). However, these homologues have different molecular weights. It is likely that this difference is due to post-translational modifications rather than changes in the gene sequence, since these proteins are highly conserved (Ramajo-Hernández et al. 2007a, b ; Sotillo et al. 2008). Furthermore, these proteins are important for the host-parasite relationship (E/S products, immunogenic properties), so these modifications could be involved in the host-parasite surface interaction. Protein disulfide isomerase (PDI) catalyses the formation (oxidation), breakage (reduction) and rearrangement (isomerisation) of disulfide bonds within proteins, thereby permitting their proper folding in the endoplasmic reticulum and transit through the secretory pathway (Ellgaard and Ruddock, 2005). PDI has been identified in the E/S products of adult E. caproni, E. friedi and F. hepatica worms, suggesting that it may be important in host-parasite interactions (Salazar-Calderon et al. 2003; Bernal et al. 2006; Sotillo et al. 2010). Moreover, PDI is immunogenic in human S. haematobium infections (Mutapi et al. 2005) and experimental F. hepatica (Moxon et al. 2010) and it has been shown to be immunologically protective against the hookworm, Ancylostoma (Epe et al. 2007). Differences in PDI molecular weight between S. haematobium and E. caproni could be due to post-translational modifications, akin to the PDI glycosylation reported in Trypansoma brucei where it is related to parasite defence (Rubotham et al. 2005).

The main function of glutathione S-transferase (GST) is detoxification of oxygen and endogenous free radicals (Torres-Rivera and Landa, 2008). It is present in Echinostoma spp. and S. bovis tegument and E/S products (Bernal et al. 2006; Perez-Sanchez et al. 2006; Sotillo et al. 2010). It is also the leading schistosome vaccine candidate (Capron et al. 2005; McManus and Loukas, 2008). There is a difference in the theoretical and observed molecular weights for GST. Ramajo-Hernandez et al. (2007a) reported no glycosylation of GST in S. bovis. Enolase is a multifunctional glycolytic enzyme (Pancholi, 2001), also present in E/S products (Bernal et al. 2006; Perez-Sanchez et al. 2006; Sotillo et al. 2010). In S. bovis as well as E. caproni, enolase has been identified as a human plasminogen-binding protein; this protein may be involved in preventing blood clotting during feeding in Schistosoma (Ramajo-Hernández et al. 2007b) or in mucosal erosion in Echinostoma (Marcilla et al. 2007).

To investigate some of the biological differences arising from differences in the proteomes, the immunogenicity of the adult worm antigens was compared. There was cross-reactivity between the three trematode species, but the intensity and antigen pattern recognition patterns differed. The most immune cross-reactivity occurred between the two schistosomes which is consistent with the DIGE results. We have identified a novel antigen for E. caproni, 3 isoforms of GADPH. E. caproni GAPDH was also recognized by sera from S. haematobium-infected hamsters. Interestingly, S. haematobium GADPH antigen was not recognized by sera from E. caproni-infected hamsters. GAPDH's immunogenicity has been reported from other studies and is one of the World Health Organisation's human schistosome vaccine candidates (Bergquist et al. 2002; El Ridi et al. 2010). Nevertheless it has not previously been reported as an antigen in Echinostoma spp. Toledo et al. (2004) discovered an immunogen of 37 kDa, 6 weeks post Echinostoma infections in rats, but the intensity of this response declined during the infection, suggesting that the protein could be released in the juvenile stages of the parasites. This immunogen is likely to be GAPDH and this present study and that of Toledo et al. (2004) suggest that the kinetics of antigen release and antibody production against GAPDH require further investigation, especially in the future context of screening against human sera from infected people.

Schistosomiasis continues to be a major public health problem in several tropical and sub-tropical countries. There are now several studies (e.g. Garba et al. 2010), showing that children as young as 1 year old are infected and can harbour levels of infection comparable to those in the adults in their communities and the search for an effective vaccine continues to be a key priority (Secor and Colley, 2005). One promising approach being pursued is to treat people, children in particular, repeatedly with praziquantel to induce immune-mediated resistance to re-infection (Black et al 2010a). However, studies using this protocol indicate that the number of PZQ treatments required to reduce re-infection is significantly variable and can take several rounds of PZQ treatment (Black et al. 2010b). This suggests that an integrated approach using treatment and a recombinant vaccine as proposed by the World Health Organisation (Berquist, 2004) might lend predictability and consistency as well as improved efficacy to future schistosome control programmes. Thus the molecular phenotypic differences shown in this study, particularly those which appear to be post-translational, may influence the development and production of recombinant vaccines (e.g. bacterial expression systems may not process the proteins appropriately after translation) and affect the efficacy of future vaccines.

Overall this study has demonstrated that, despite several biological and phylogenetic similarities between the three trematode species S. haematobium, S. bovis and E. caproni, there are quantitative and qualitative differences in protein expression patterns in their adult worm proteomes. The differences could be due to phenotypic plasticity arising from different host-parasite relationships. Some of these differences translate to differences in immunogenicity. Further studies characterizing the differentially expressed proteins will be important in determining the identity of proteins involved in host-parasite adaptation and the nature of the interaction between the host and parasite. This is particularly important for identifying vaccine candidates and predicting the effects vaccination, especially in childhood, would have on the parasite population structure.

ACKNOWLEDGEMENTS

We are grateful for the donation of CyDye DIGE Fluor minimal dyes by GE Healthcare. We also thank Alan Scott, University of Glasgow for technical support.

FINANCIAL SUPPORT

This work was supported by the Carnegie Trust for the Universities of Scotland; the Wellcome Trust (Grant no WT082028MA); and a predoctoral fellowship from the Spanish Ministry of Science and Education (MH).

REFERENCES

  1. Agnew A. M., Murare H. M., Lucas S. B., Doenhoff M. J.. Schistosoma bovis as an immunological analogue of S. haematobium. Parasite Immunology. 1989;11:329–340. doi: 10.1111/j.1365-3024.1989.tb00671.x. [DOI] [PubMed] [Google Scholar]
  2. Aquadro C. F., Avise J. C.. Genetic divergence between rodent species assessed by using two-dimensional electrophoresis. Proceedings of the National Academy of Sciences, USA. 1981;78:3784–3788. doi: 10.1073/pnas.78.6.3784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bergquist R. 2004. http://www.who.int/tdrold/publications/tdrnews/news71/schisto.htm http://www.who.int/tdrold/publications/tdrnews/news71/schisto.htm . Accessed 26 January 2011.
  4. Bergquist R., Al-Sherbiny M., Barakat R., Olds R.. Blueprint for schistosomiasis vaccine development. Acta Tropica. 2002;82:183–192. doi: 10.1016/s0001-706x(02)00048-7. [DOI] [PubMed] [Google Scholar]
  5. Bergquist R., Utzinger J., McManus D. P.. Trick or Treat: the role of vaccines in integrated schistosomiasis control. PLoS Neglected Tropical Diseases. 2008;2:e244. doi: 10.1371/journal.pntd.0000244. . doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bernal D., Carpena I., Espert A. M., De la Rubia J. E., Esteban J. G., Toledo R., Marcilla A.. Identification of proteins in excretory/secretory extracts of Echinostoma friedi (Trematoda) from chronic and acute infections. Proteomics. 2006;6:2835–2843. doi: 10.1002/pmic.200500571. [DOI] [PubMed] [Google Scholar]
  7. Berriman M., Haas B. J., LoVerde P. T., Wilson R. A., Dillon G. P., Cerqueira G. C., Mashiyama S. T., Al-Lazikani B., Andrade L. F., Ashton P. D., Aslett M. A., Bartholomeu D. C., Blandin G., Caffrey C. R., Coghlan A., Coulson R., Day T. A., Delcher A., DeMarco R., Djikeng A., Eyre T., Gamble J. A., Ghedin E., Gu Y., Hertz-Fowler C., Hirai H., Hirai Y., Houston R., Ivens A., Johnston D. A., Lacerda D., Macedo C. D., McVeigh P., Ning Z., Oliveira G., Overington J. P., Parkhill J., Pertea M., Pierce R. J., Protasio A. V., Quail M. A., Rajandream M. A., Rogers J., Sajid M., Salzberg S. L., Stanke M., Tivey A. R., White O., Williams D. L., Wortman J., Wu W., Zamanian M., Zerlotini A., Fraser-Liggett C. M., Barrell B. G., El-Sayed N. M.. The genome of the blood fluke Schistosoma mansoni. Nature. 2009;460:352–358. doi: 10.1038/nature08160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Black C. L. Muok E. M. Mwinzi P. N. Carter J. M. Karanja D. M. Secor W. E. Colley D. G. 2010aIncreases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni Journal of Infectious Diseases 202399–405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Black C. L. Mwinzi P. N. Muok E. M. Abudho B. Fitzsimmons C. M. Dunne D. W. Karanja D. M. Secor W. E. Colley D. G. 2010bInfluence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni PLoS Neglected Tropical Diseases 4e637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bowles J., Blair D., McManus D. P.. A molecular phylogeny of the human schistosomes. Molecular Phylogenetics and Evolution. 1995;4:103–109. doi: 10.1006/mpev.1995.1011. [DOI] [PubMed] [Google Scholar]
  11. Capron A., Riveau G., Capron M., Trottein F.. Schistosomes: the road from host–parasite interactions to vaccines in clinical trials. Trends in Parasitology. 2005;21:143–149. doi: 10.1016/j.pt.2005.01.003. [DOI] [PubMed] [Google Scholar]
  12. Cheng G. F., Lin J. J., Feng X. G., Fu Z. Q., Jin Y. M., Yuan C. X., Zhou Y. C., Cai Y. M.. Proteomic analysis of differentially expressed proteins between the male and female worm of Schistosoma japonicum after pairing. Proteomics. 2005;5:511–521. doi: 10.1002/pmic.200400953. [DOI] [PubMed] [Google Scholar]
  13. Cieslak A., Ribera I.. Aplicaciones de proteómica en ecología y evolución. Ecosistemas. 2009;18:34–43. [Google Scholar]
  14. Curwen R. S., Ashton P. D., Johnston D. A., Wilson R. A.. The Schistosoma mansoni soluble proteome: a comparison across four life-cycle stages. Molecular and Biochemical Parasitology. 2004;138:57–66. doi: 10.1016/j.molbiopara.2004.06.016. [DOI] [PubMed] [Google Scholar]
  15. Demeure C. E., Rihet P., Abel L., Ouattara M., Bourgois A., Dessein A. J.. Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. Journal of Infectious Diseases. 1993;168:1000–1008. doi: 10.1093/infdis/168.4.1000. [DOI] [PubMed] [Google Scholar]
  16. Doenhoff M. J., Hagan P., Cioli D., Southgate V., Pica-Mattoccia L., Botros S., Coles G., Tchueme-Tuchuente L. A., Mbaye A.. Engels D.. Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs. Parasitology. 2009;136:1825–1835. doi: 10.1017/S0031182009000493. , and . [DOI] [PubMed] [Google Scholar]
  17. Dunne D. W., Butterworth A., Fulford A. J., Ouma J. H., Sturrock B. F.. Human IgE responses to Schistosoma mansoni and resistance to reinfection. Memorias do Instituto do Oswaldo Cruz. 1992;87:99–103. doi: 10.1590/s0074-02761992000800014. [DOI] [PubMed] [Google Scholar]
  18. Ellgaard L., Ruddock L. W.. The human protein disulphide isomerase family: substrate interactions and functional properties. EMBO Reports. 2005;6:28–32. doi: 10.1038/sj.embor.7400311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. El Ridi R., Tallima H., Mahana N., Dalton J. P.. Innate immunogenicity and in vitro protective potential of Schistosoma mansoni lung schistosomula excretory-secretory candidate vaccine antigens. Microbes and Infection. 2010;12:700–709. doi: 10.1016/j.micinf.2010.04.012. [DOI] [PubMed] [Google Scholar]
  20. Engels D., Chitsulo L., Montresor A., Savioli L.. The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Tropica. 2002;82:139–146. doi: 10.1016/s0001-706x(02)00045-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Epe C., Behrens C., Strube C., Schnieder T.. Evaluation of the transcription level of the protein disulfide isomerase in different stages from Ancylostoma caninum with a real-time PCR assay. Parasitology Research. 2007;101:1589–1595. doi: 10.1007/s00436-007-0679-4. [DOI] [PubMed] [Google Scholar]
  22. Garba A., Barkier N., Djibo A., Lamine M. S., Sofo B., Gouras A. N., Bosque-Oliva E., Webster J. P., Stothard J. R., Utzinger J., Fenwick A.. Schistosomiasis in infants and preschool-aged children: infection in a single Schistosoma haematobium and a mixed S. haematobium-S. mansoni foci of Niger. Acta Tropica. 2010;115:212–219. doi: 10.1016/j.actatropica.2010.03.005. [DOI] [PubMed] [Google Scholar]
  23. Grogan J., Kremsner P. J., Van Dam G. J., Deelder A. M., Yazdanbakhsh M.. Anti-schistosome IgG4 and IgE at 2 years after chemotherapy: infected versus uninfected individuals. Journal of Infectious Diseases. 1997;176:1344–1350. doi: 10.1086/514131. [DOI] [PubMed] [Google Scholar]
  24. Hagan P., Blumenthal U. J., Dunne D., Simpson A. J. D., Wilkins A. H.. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature. 1991;349:234–245. doi: 10.1038/349243a0. [DOI] [PubMed] [Google Scholar]
  25. Hagan P., Sharaf O.. Schistosomiasis vaccines. Expert Opinion in Biological Therapy. 2003;3:1271–1278. doi: 10.1517/14712598.3.8.1271. [DOI] [PubMed] [Google Scholar]
  26. Harnett W., Harnett M. M.. Helminth-derived immunomodulators: can understanding the worm produce the pill. Nature Reviews Immunology. 2010;10:278–284. doi: 10.1038/nri2730. [DOI] [PubMed] [Google Scholar]
  27. Higón M., Monteagudo C., Fried B., Esteban J. G., Toledo R., Marcilla A.. Molecular cloning and characterization of Echinostoma caproni heat shock protein-70 and differential expression in the parasite derived from low- and high-compatible hosts. Parasitology. 2008;135:1469–1477. doi: 10.1017/S0031182008004927. [DOI] [PubMed] [Google Scholar]
  28. Hirsh A. E., Fraser H. B.. Protein dispensability and rate of evolution. Nature. 2001;411:1046–1049. doi: 10.1038/35082561. [DOI] [PubMed] [Google Scholar]
  29. Huyse T., Webster B. L., Geldof S., Stothard J. R., Diaw O. T., Polman K., Rollinson D.. Bidirectional introgressive hybridization between a cattle and human schistosome species. PLoS Pathogens. 2009;5:e1000571. doi: 10.1371/journal.ppat.1000571. . doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Jolly E. R., Chin C. S., Miller S., Bahgat M. M., Lim K. C., DeRisi J., McKerrow J. H.. Gene expression patterns during adaptation of a helminth parasite to different environmental niches. Genome Biology. 2007;8:R65. doi: 10.1186/gb-2007-8-4-r65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. López J. L.. Two-dimensional electrophoresis in proteome expression analysis. Journal of Chromatography. 2007;849:190–202. doi: 10.1016/j.jchromb.2006.11.049. [DOI] [PubMed] [Google Scholar]
  32. Losada S., Chacón N., Colmenares C., Bermúdez H., Lorenzo A., Pointier J. P., Theron A., Alarcón de Noya B., Noya O.. Schistosoma: Cross-reactivity and antigenic community among different species. Experimental Parasitology. 2005;111:182–190. doi: 10.1016/j.exppara.2005.07.007. [DOI] [PubMed] [Google Scholar]
  33. Marcilla A., Perez-Garcia A., Espert A., Bernal D., Muñoz-Antoli C., Esteban J. G., Toledo R.. Echinostoma caproni: identification of enolase in excretory/secretory products, molecular cloning, and functional expression. Experimental Parasitology. 2007;117:57–64. doi: 10.1016/j.exppara.2007.03.011. [DOI] [PubMed] [Google Scholar]
  34. McManus D. P., Loukas A.. Current status of vaccines for schistosomiasis. Clinical Microbiology Reviews. 2008;21:225–242. doi: 10.1128/CMR.00046-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Midzi N., Sangweme D., Zinyowera S., Mapingure M., Brouwer K. C., Munatsi A., Mutapi F., Mudzori J., Kumar N., Woelk G., Mduluza T.. The burden of polyparasitism among primary schoolchildren in rural and farming areas in Zimbabwe. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2008;102:1039–1045. doi: 10.1016/j.trstmh.2008.05.024. [DOI] [PubMed] [Google Scholar]
  36. Moxon J. V., Flynn A. R. J., Golden A. O., Hamilton J. V., Mulcahy G., Brophy M. P.. Immune responses directed at egg proteins during experimental infection with the liver fluke Fasciola hepatica. Parasite Immunology. 2010;32:111–124. doi: 10.1111/j.1365-3024.2009.01171.x. [DOI] [PubMed] [Google Scholar]
  37. Mutapi F., Burchmore R., Mduluza T., Foucher A., Harcus Y., Nicoll G., Midzi N., Turner C. M., Maizels R. M.. Praziquantel treatment of individuals exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens. Journal of Infectious Diseases. 2005;192:1108–1118. doi: 10.1086/432553. [DOI] [PubMed] [Google Scholar]
  38. Mutapi F., Ndlovu P. D., Hagan P., Spicer J. T., Mduluza T., Turner C. M., Chandiwana S. K., Woolhouse M. E. J.. Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection. Journal of Infectious Diseases. 1998;178:289–293. doi: 10.1086/517456. [DOI] [PubMed] [Google Scholar]
  39. Nowak T. S., Loker E. S.. Echinostoma paraensei: differential gene transcription in the sporocyst stage. Experimental Parasitology. 2005;109:94–105. doi: 10.1016/j.exppara.2004.11.005. [DOI] [PubMed] [Google Scholar]
  40. Oleaga A., Ramajo V.. Efficiency of the oral, intramuscular and subcutaneous routes for the experimental infection of hamster and sheep with Schistosoma bovis. Veterinary Parasitology. 2004;124:43–53. doi: 10.1016/j.vetpar.2004.06.022. [DOI] [PubMed] [Google Scholar]
  41. Pancholi V.. Multifunctional alpha-enolase: its role in diseases. Cellular and Molecular Life Science: CMLS. 2001;58:902–920. doi: 10.1007/PL00000910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Pérez-Sánchez R., Ramajo-Hernández A., Ramajo-Martín V., Oleaga A.. Proteomic analysis of the tegument and excretory-secretory products of adult Schistosoma bovis worms. Proteomics. 2006;6:S226–S236. doi: 10.1002/pmic.200500420. [DOI] [PubMed] [Google Scholar]
  43. Ramajo-Hernandez A. Oleaga A. Ramajo-Martın V. Perez-Sanchez R. 2007aCarbohydrate profiling and protein identification of tegumental and excreted/secreted glycoproteins of adult Schistosoma bovis worms Veterinary Parasitology 14445–60. [DOI] [PubMed] [Google Scholar]
  44. Ramajo-Hernández A. Pérez-Sánchez R. Ramajo-Martín V. Oleaga A. 2007bSchistosoma bovis: Plasminogen binding in adults and the identication of plasminogen-binding proteins from the worm tegument Experimental Parasitology 11583–91. [DOI] [PubMed] [Google Scholar]
  45. Ramm S. A., McDonald L., Hurst J. L., Beynon R. J., Stockley P.. Comparative proteomics reveals evidence for evolutionary diversification of rodent seminal fluid and its functional significance in sperm competition. Molecular Biology and Evolution. 2009;26:189–198. doi: 10.1093/molbev/msn237. [DOI] [PubMed] [Google Scholar]
  46. Rollinson D., Kaukas A., Johnston D. A., Simpson A. J., Tanaka M.. Some molecular insights into schistosome evolution. International Journal for Parasitology. 1997;27:11–28. doi: 10.1016/s0020-7519(96)00169-5. [DOI] [PubMed] [Google Scholar]
  47. Rubotham J., Woods K., Garcia-Salcedo J. A., Pays E., Nolan D. P.. Characterization of two protein disulfide isomerases from the endocytic pathway of bloodstream forms of Trypanosoma brucei. Journal of Biological Chemistry. 2005;280:10410–10418. doi: 10.1074/jbc.M409375200. [DOI] [PubMed] [Google Scholar]
  48. Salazar-Calderón M., Martín-Alonso M. J., Castro A. M., Parra F.. Cloning, heterologous expression in Escherichia coli and characterization of a protein disulfide isomerase from Fasciola hepatica. Molecular and Biochemical Parasitology. 2003;126:15–23. doi: 10.1016/s0166-6851(02)00269-4. [DOI] [PubMed] [Google Scholar]
  49. Schrimpf S. P., Hengartner M. O.. A worm rich in protein: Quantitative, differential, and global proteomics in Caenorhabditis elegans. Journal of Proteomics. 2010;73:2186–2197. doi: 10.1016/j.jprot.2010.03.014. [DOI] [PubMed] [Google Scholar]
  50. Secor W. E., Colley D. G. Schistosomiasis. World Class Parasite Series. Springer; New York: 2005. [Google Scholar]
  51. Sirag S. B., Christensen N. O., Frandsen F., Monrad J., Nansen P.. Homologous and heterologous resistance in Echinostoma revolutum infections in mice. Parasitology. 1980;80:479–486. doi: 10.1017/s0031182000000949. [DOI] [PubMed] [Google Scholar]
  52. Smith R. E., Spithill T. W., Pike R. N., Meeusen E. N. T., Piedrafita D.. Fasciola hepatica and Fasciola gigantica: cloning and characterization of 70 Kda heat-shock proteins reveals variation in HSP70 gene expression between parasite species recovered from sheep. Experimental Parasitology. 2008;118:536–542. doi: 10.1016/j.exppara.2007.11.012. [DOI] [PubMed] [Google Scholar]
  53. Sotillo J., Valero L., Sanchez Del Pino M. M., Fried B., Esteban J. G., Marcilla A., Toledo R.. Identification of antigenic proteins from Echinostoma caproni (Trematoda) recognized by mouse immunoglobulins M, A and G using an immunoproteomic approach. Parasite Immunology. 2008;30:271–279. doi: 10.1111/j.1365-3024.2007.01019.x. [DOI] [PubMed] [Google Scholar]
  54. Sotillo J., Valero M. L., Sánchez Del Pino M. M., Fried B., Esteban J. G., Marcilla A., Toledo R.. Excretory/secretory proteome of the adult stage of Echinostoma caproni. Parasitology Research. 2010;107:691–697. doi: 10.1007/s00436-010-1923-x. [DOI] [PubMed] [Google Scholar]
  55. Soulsby E. J. L. Helminths, Arthropods and Protozoa of Domesticated Animals. 7th Edn. Bailliere-Tindall; London: 1986. [Google Scholar]
  56. Stoever K., Molyneux D., Hotez P., Fenwick A.. HIV/AIDS, schistosomiasis, and girls. Lancet. 2009;13:2025–2026. doi: 10.1016/S0140-6736(09)61111-9. [DOI] [PubMed] [Google Scholar]
  57. Stothard J. R., Mgeni A. F., Khamis S., Seto E., Ramsan M., Rollinson D.. Urinary schistosomiasis in schoolchildren on Zanzibar Island (Unguja), Tanzania: a parasitological survey supplemented with questionnaires. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2002;96:507–514. doi: 10.1016/s0035-9203(02)90421-9. [DOI] [PubMed] [Google Scholar]
  58. Toledo R., Espert A., Carpena I., Muñoz-Antoli C., Esteban J. G.. An experimental study of the reproductive success of Echinostoma friedi (Trematoda: Echinostomatidae) in the golden hamster. Parasitology. 2003;126:433–441. doi: 10.1017/s0031182003213068. [DOI] [PubMed] [Google Scholar]
  59. Toledo R., Espert A., Munoz-Antoli C., Fried B., Esteban J. G.. Immunological characterization of somatic and excretory/secretory antigens of Echinostoma caproni (Trematoda: Echinostomatidae) in experimentally infected rats. Comparative Parasitology. 2004;71:42–48. [Google Scholar]
  60. Toledo R., Esteban J. G., Fried B.. Recent advances in the biology of echinostomes. Advances in Parasitology. 2009;69:147–204. doi: 10.1016/S0065-308X(09)69003-5. [DOI] [PubMed] [Google Scholar]
  61. Toledo R., Fried B.. Echinostomes as experimental models for interactions between adult parasites and vertebrate hosts. Trends in Parasitology. 2005;21:251–254. doi: 10.1016/j.pt.2005.04.006. [DOI] [PubMed] [Google Scholar]
  62. Torres-Rivera A., Landa A.. Cooperative kinetics of the recombinant glutathione transferase of Taenia solium and characterization of the enzyme. Archives of Biochemistry and Biophysics. 2008;477:372–378. doi: 10.1016/j.abb.2008.07.008. [DOI] [PubMed] [Google Scholar]
  63. Trottein F., Godin C., Pierce R. J., Sellin B., Taylor M. G., Gorillot I., Silva M. S., Lecocq J. P., Capron A.. Inter-species variation of schistosome 28-kDa glutathione S-transferases. Molecular and Biochemical Parasitology. 1992;54:63–72. doi: 10.1016/0166-6851(92)90095-2. [DOI] [PubMed] [Google Scholar]
  64. Vercruysse J., Gabriel S.. Immunity to schistosomiasis in animals: an update. Parasite Immunology. 2005;27:289–295. doi: 10.1111/j.1365-3024.2005.00766.x. [DOI] [PubMed] [Google Scholar]
  65. Verjovski-Almeida S., DeMarco R., Martins E. A., Guimaraes P. E., Ojopi E. P., Paquola A. C., Piazza J. P., Nishiyama M. Y. Jr, Kitajima J. P., Adamson R. E., Ashton P. D., Bonaldo M. F., Coulson P. S., Dillon G. P., Farias L. P., Gregorio S. P., Ho P. L., Leite R. A., Malaquias L. C., Marques R. C., Miyasato P. A., Nascimento A. L., Ohlweiler F. P., Reis E. M., Ribeiro M. A., Sa R. G., Stukart G. C., Soares M. B., Gargioni C., Kawano T., Rodrigues V., Madeira A. M., Wilson R. A., Menck C. F., Setubal J. C., Leite L. C., Dias-Neto E.. Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni. Nature Genetics. 2003;35:148–157. doi: 10.1038/ng1237. [DOI] [PubMed] [Google Scholar]
  66. Wang Z., Abubucker S., Martin J., Wilson R. K., Hawdon H. J., Mitreva M.. Characterizing Ancylostoma caninum transcriptome and exploring nematode parasitic adaptation. BMC Genomics. 2010;11:307. doi: 10.1186/1471-2164-11-307. . doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Webster B. L., Southgate V. R., Littlewood D. T.. A revision of the interrelationships of Schistosoma including the recently described Schistosoma guineensis. International Journal for Parasitology. 2006;36:947–955. doi: 10.1016/j.ijpara.2006.03.005. [DOI] [PubMed] [Google Scholar]
  68. Zhou Y., Zheng H., Chen Y., Zhang L., Wang K., Guo J., Huang Z., Zhang B., Huang W., Jin K., Dou T., Hasegawa M., Wang L., Zhang Y., Zhou J., Tao L., Cao Z., Li Y., Vinar T., Brejova B., Brown D., Li M., Miller D. J., Blair D., Zhong Y., Chen Z., Liu F., Hu W., Wang Z. Q., Zhang Q. H., Song H. D., Chen S., Xu X., Xu B., Ju C., Huang Y., Brindley P. J., McManus D. P., Feng Z., Han Z. G., Lu G., Ren S., Wang Y., Gu W., Kang H., Chen J., Chen X., Chen S., Wang L., Yan J., Wang B., Lv X., Jin L., Wang B., Pu S., Zhang X., Zhang W., Hu Q., Zhu G., Wang J., Yu J., Wang J., Yang H., Ning Z., Beriman M., Wei C. L., Ruan Y., Zhao G., Wang S., Liu F., Zhou Y., Wang Z. Q., Lu G., Zheng H., Brindley P. J., McManus D. P., Blair D., Zhang Q. H., Zhong Y., Wang S., Han Z. G., Chen Z., Wang S., Han Z. G., Chen Z.. The Schistosoma japonicum genome reveals features of host–parasite interplay. Nature. 2009;460:345–351. doi: 10.1038/nature08140. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Parasitology are provided here courtesy of Cambridge University Press

RESOURCES